Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01949662 · ClinicalTrials.gov registry record · Phase 2

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

A Phase 2 study of Advanced Cancers, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
Phase 2
Development phase
93
Enrollment target
1
Study location

NCT01949662 is a Phase 2 study of Advanced Cancers that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 93 participants, above the 61-participant average among 10 other Advanced Cancers trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01949662, a Phase 2 study of Advanced Cancers, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
93 participants
Enrollment target
1
Study location

Study Summary

This randomized phase II trial studies how well haloperidol with or without lorazepam works in reducing confusion, disorientation, and inability to think or remember clearly (delirium) in patients with cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment. Palliative therapy with haloperidol and lorazepam may reduce symptoms of delirium and help patients with advanced cancer live more comfortably. It is not yet known whether lorazepam may be an effective treatment for delirium when given with haloperidol.

Conditions Studied

Advanced Cancers

Interventions

  • DRUG Placebo
  • BEHAVIORAL Questionnaires
  • DRUG Lorazepam
  • DRUG Haloperidol decanoate

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2014-01
Est. Completion 2028-01-01
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01949662

The ClinicalTrials.gov registry entry for NCT01949662 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 10 other Advanced Cancers trials with a reported enrollment target (52% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Cancers appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT01949662 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01949662 about?

NCT01949662 is a clinical study titled "Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer". This randomized phase II trial studies how well haloperidol with or without lorazepam works in reducing confusion, disorientation, and inability to think or remember clearly (delirium) in patients with cancer that has spread to other places in the body and usually cannot be cured or controlled with ...

What is the current status of trial NCT01949662?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 93 participants. The study started on 2014-01. Estimated completion is 2028-01-01.

What conditions does trial NCT01949662 study?

This clinical trial studies the following conditions: Advanced Cancers.

What interventions are being tested in trial NCT01949662?

The interventions under investigation include: Placebo (DRUG), Questionnaires (BEHAVIORAL), Lorazepam (DRUG), Haloperidol decanoate (DRUG).

Who is sponsoring clinical trial NCT01949662?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01949662 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Cancers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Cancers

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.